MCMira-Lynn Chavanon

Mira-Lynn Chavanon

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Mira-Lynn Chavanon has a total of 71 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Symptom and Performance Validity Measures in the Clinical Assessment of Adult ADHD: What Do We Learn from Network Analysis?

    by Anselm B. M. Fuermaier, Oliver Hirsch, Björn Albrecht, Mira-Lynn Chavanon, Hanna Christiansen

    Background: First-time diagnoses of attention-deficit/hyperactivity disorder (ADHD) in adults can be challenging due to diverse methodologies available for assessment, and the choices clinicians need to make about how to interpret diagnostic criteria. Network analysis is a statistical approach that has received growing attention in clinical research of recent years. It has the potential to aid visualization and illustrate the intricate relationships between the wide range of clinical measures. Aim: The goal of the present study is to examine the value of network analysis on a sample of N = 896 adults newly diagnosed with ADHD in an outpatient referral context. Method and Results: The network depicts the interrelationship of a comprehensive set of measures and test variables, including symptom self- and other-reports, cognitive tests, motor activity, as well as measures of symptom and performance validity. Conclusion: Our network analysis supports ADHD symptom clusters with distinct networks of motor activity and attention/impulsivity and reflects the mode of assessment, i.e., neuropsychological versus self- and observer-ratings. The network further depicts the dissociable role of symptom and performance validity measures, and the different nature of embedded and freestanding validity tests. We discuss the future application of network analysis in clinical research on ADHD.


  • Open Access

    A Blended Learning Course on the Diagnostics of Mental Disorders: Multicenter Cluster Randomized Noninferiority Trial

    by Gabriel Bonnin, Svea Kröber, Silvia Schneider, Jürgen Margraf, Verena Pflug, Alexander L Gerlach, Timo Slotta, Hanna Christiansen, Björn Albrecht, Mira-Lynn Chavanon, et al.

    Background: Clinical diagnoses determine if and how therapists treat their patients. As misdiagnoses can have severe adverse effects, disseminating evidence-based diagnostic skills into clinical practice is highly important. Objective: This study aimed to develop and evaluate a blended learning course in a multicenter cluster randomized controlled trial. Methods: Undergraduate psychology students (N=350) enrolled in 18 university courses at 3 universities. The courses were randomly assigned to blended learning or traditional synchronous teaching. The primary outcome was the participants’ performances in a clinical diagnostic interview after the courses. The secondary outcomes were diagnostic knowledge and participants’ reactions to the courses. All outcomes were analyzed on the individual participant level using noninferiority testing. Results: Compared with the synchronous course (74.6% pass rate), participation in the blended learning course (89% pass rate) increased the likelihood of successfully passing the behavioral test (odds ratio 2.77, 95% CI 1.55-5.13), indicating not only noninferiority but superiority of the blended learning course. Furthermore, superiority of the blended learning over the synchronous course could be found regarding diagnostic knowledge (β=.13, 95% CI 0.01-0.26), course clarity (β=.40, 95% CI 0.27-0.53), course structure (β=.18, 95% CI 0.04-0.32), and informativeness (β=.19, 95% CI 0.06-0.32). Conclusions: Blended learning can help to improve the diagnostic skills and knowledge of (future) clinicians and thus make an important contribution to improving mental health care. Trial Registration: ClinicalTrials.gov NCT05294094; https://clinicaltrials.gov/study/NCT05294094


  • Open Access

    Pilot study of implementing Managing and Adapting Practice in a German psychotherapy master’s program

    by Katharina Szota, Anna S. van der Meer, Teri Bourdeau, Bruce F. Chorpita, Mira-Lynn Chavanon, Hanna Christiansen

    Despite a significant accumulation of research, there has been little systemic implementation of evidence-based practices (EBP) in youth mental health care. The fragmentation of the evidence base complicates implementation efforts. In light of this challenge, we sought to pilot a system that consolidates and coordinates the entire evidence base in a single direct service model (i.e., Managing and Adapting Practice; MAP) in the context of a legal reform of psychotherapy training in Germany. This pilot study aimed to evaluate the feasibility of the implementation of MAP into the curriculum of the reformed German master's program. Eligible participants were students in the master’s program at Philipps-University Marburg during the winter-term 2022/2023. Students first learned about MAP through introductions and role plays (seminar 1), followed by actively planning and conducting interventions using MAP resources for patients in a case seminar under supervision (seminar 2). A repeated-measures survey was conducted to investigate students’ knowledge gains, perception of MAP and changes in their self-rated confidence to use EBP. Results indicated that students perceive MAP to be manageable to learn. Positive progress was achieved with regard to their knowledge and self-reported confidence to use EBP, although interpretation and generalization of the results are limited by small and homogeneous samples, lack of statistical power and missing comparison groups. The feasibility of the implementation and suitability of measures are discussed. Important implications could be drawn with regard to future investigations.


  • Open Access

    A Blended Learning Course on the Diagnostics of Mental Disorders: Multicenter Cluster Randomized Noninferiority Trial (Preprint)

    by Gabriel Bonnin, Svea Kröber, Silvia Schneider, Jürgen Margraf, Verena Pflug, Alexander L Gerlach, Timo Slotta, Hanna Christiansen, Björn Albrecht, Mira-Lynn Chavanon, et al.

    BACKGROUND Clinical diagnoses determine if and how therapists treat their patients. As misdiagnoses can have severe adverse effects, disseminating evidence-based diagnostic skills into clinical practice is highly important. OBJECTIVE This study aimed to develop and evaluate a blended learning course in a multicenter cluster randomized controlled trial. METHODS Undergraduate psychology students (N=350) enrolled in 18 university courses at 3 universities. The courses were randomly assigned to blended learning or traditional synchronous teaching. The primary outcome was the participants’ performances in a clinical diagnostic interview after the courses. The secondary outcomes were diagnostic knowledge and participants’ reactions to the courses. All outcomes were analyzed on the individual participant level using noninferiority testing. RESULTS Compared with the synchronous course (74.6% pass rate), participation in the blended learning course (89% pass rate) increased the likelihood of successfully passing the behavioral test (odds ratio 2.77, 95% CI 1.55-5.13), indicating not only noninferiority but superiority of the blended learning course. Furthermore, superiority of the blended learning over the synchronous course could be found regarding diagnostic knowledge (β=.13, 95% CI 0.01-0.26), course clarity (β=.40, 95% CI 0.27-0.53), course structure (β=.18, 95% CI 0.04-0.32), and informativeness (β=.19, 95% CI 0.06-0.32). CONCLUSIONS Blended learning can help to improve the diagnostic skills and knowledge of (future) clinicians and thus make an important contribution to improving mental health care. CLINICALTRIAL ClinicalTrials.gov NCT05294094; https://clinicaltrials.gov/study/NCT05294094


  • Open Access

    Neurocognitive Dynamics of Preparatory and Adaptive Cognitive Control: Insights from Mass-Univariate and Multivariate Pattern Analysis of EEG data

    by José C. García Alanis, Malte R. Güth, Mira-Lynn Chavanon, Martin Peper

    Cognitive control encompasses a set of basic perceptual and reasoning processes that help us align thoughts and actions with goals. While a growing body of research indicates that these processes can be independently engaged and tuned to fit different tasks (e.g., behavioural preparation vs behavioural adaptation), the dynamic interplay of these processes and their functional timing within the information stream, remains elusive. In this study, we used a combination of mass-univariate and multivariate pattern analysis to examine electroencephalography data from 52 participants, recorded during performance of the Dot Pattern Expectancy Task (DPX), a task designed to assess both preparatory and adaptive cognitive control. Contrary to the notion of isolated neural signatures for either cognitive control mode, our data indicates that cognitive control engages a sequence of distinct yet partially overlapping brain activation patterns. Preparatory cue-stimuli evoked early transient occipital-parietal amplitude responses that were followed by enhanced sustained central-parietal and fronto-central amplitude responses. Similarly, adaptive probe-stimuli evoked enhanced early transient occipital-parietal amplitude responses, but these were followed by enhanced transient, fronto-central and central parietal amplitude responses. Moreover, we found significant relationships between the magnitude of the central-parietal and fronto-central amplitude response pattern and behavioural performance in the DPX. This research not only extends prior work but also offers valuable insights into the functional timing and organisation of the neurocognitive processes underpinning both preparatory and adaptive cognitive control.

  • How family history of premature myocardial infarction affects patients at cardiovascular risk.

    by Jonas Nagel, Mira-Lynn Chavanon, Lutz Binder, Annekatrin Pieper, Rolf Wachter, Frank Edelmann, Christoph Herrmann-Lingen

    Family history of premature myocardial infarction (FH-MI) increases the risk for coronary heart disease (CHD). Research has shown that this effect cannot be accounted for by increased genetic vulnerability alone. We tested the hypothesis that FH-MI is associated with psychological distress, which is known to increase CHD risk, and that this effect is sustained over years and mediated by personality traits and coping strategies. Levels of distress (i.e., exhaustion, depression, and anxiety) were compared between patients with versus without FH-MI and those with versus without own history of myocardial infarction (MI) from the large observational Diagnostic trial on Prevalence and Clinical Course of Diastolic Dysfunction and Heart Failure (DIAST-CHF) study of patients with cardiovascular risk factors or manifest heart disease (N = 1,470). FH-MI was associated with a range of personality traits and coping strategies and independently predicted psychological distress, whereas own MI did not. In mediation analysis, we found that sociotropy and avoidant coping serially mediated significant portions of the effect of FH-MI on distress. Proportions of explained variance ranged from R2 = .11 for depressive symptoms to R2 = .25 for anxiety. Effects remained stable at 1-year follow-up. Several alternative hypotheses were tested and found to be less well supported by the data. Participants with cardiovascular risk factors and FH-MI report increased distress, even years after the event, which might be one component leading to their increased CHD risk. They should be offered support for dealing with distress and life events recurring on sociotropy and avoidant coping as important diathesis factors. (PsycInfo Database Record (c) 2021 APA, all rights reserved).


  • Emotionsregulation bei ADHS – kardiovagale Kontrolle als Biomarker?

    by Mira-Lynn Chavanon, Elke Riechmann, Frank A. Sattler, Simon Priester, Björn Albrecht, Bernhard Kis, Hanna Christiansen

    Zusammenfassung. In den letzten Jahren wurden die kardiovagale Kontrolle und die damit assoziierten Indizes der vagal-mediierten Herzratenvariabilität als Biomarker der physiologischen und emotionalen Aktiviertheit sowie der Emotionsregulation herausgestellt. Gerade Patienten mit einer Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung (ADHS) weisen in diesen emotionalen Facetten häufig Schwierigkeiten auf, sodass das Ziel der vorliegenden Übersichtsarbeit ist, die physiologische Ebene der emotionalen Reaktivität und Emotionsregulation am Beispiel der vagal-mediierten Herzratenvariabilität systematisch für Patienten mit ADHS zusammenzufassen. In einer Literaturrecherche konnten sieben Arbeiten (k = 5 mit Kindern und Jugendlichen; k = 2 mit Erwachsenen) identifiziert werden. Während die Studien für das Erwachsenenalter keine eindeutigen Schlüsse zulassen, weisen die Ergebnisse für das Kindes- und Jugendalter darauf hin, dass die Psychophysiologie einen Beitrag zur Identifizierung von Mechanismen der emotionalen Reaktivität und Emotionsregulation bei ADHS leisten könnte. Die größte Studie in diesem Bereich weist unterscheidbare Patientencluster mit differentiellen kardiovaskulären Profilen der Emotionsreaktivität und -regulation aus. Diese physiologische Heterogenität birgt – wenn sie sich als robust erweist – das Potential für die Entwicklung neuer Behandlungsansätze sowie für die Verbesserung bei der Zuweisung zu bestehenden Interventionen.


  • Regional differences in health-related quality of life in elderly heart failure patients: results from the CIBIS-ELD trial

    by Mira-Lynn Chavanon, Simone Inkrot, Christine Zelenak, Elvis Tahirovic, Dragana Stanojevic, Svetlana Apostolovic, Aleksandra Sljivic, Arsen D. Ristic, Dragan Matic, Goran Loncar, et al.

    Patient-reported outcomes such as health-related quality of life (HRQoL) are main treatment goals for heart failure (HF) and therefore endpoints in multinational therapy trials. However, little is known about country-specific differences in HRQoL and in treatment-associated HRQoL improvement. The present work sought to examine those questions.


  • Open Access

    Elevated Plasma C-Terminal Endothelin-1 Precursor Fragment Concentrations Are Associated with Less Anxiety in Patients with Cardiovascular Risk Factors. Results from the Observational DIAST-CHF Study

    by Thomas Meyer, Mira-Lynn Chavanon, Christoph Herrrmann-Lingen, Maren Roggenthien, Kathleen Nolte, Burkert Pieske, Rolf Wachter, Frank Edelmann

    The role of endothelin-1 (ET-1) in the neurobiology of anxiety is unknown, therefore, we assessed in the observational multicenter DIAST-CHF study whether the C-terminal ET-1 precursor fragment (CT-proET-1) is linked to anxiety. Plasma concentrations of CT-proET-1 were measured in a total of 1,410 patients presenting with cardiovascular risk factors (mean age 66.91±8.2 years, 49.3% males, mean left ventricular ejection fraction 60.0±8.2%) who had completed the Hospital Anxiety and Depression Scale (HADS) questionnaire. Among the total study cohort (n = 1,410), there were 118 subjects (8.4%) with an HADS anxiety score above the cut-off level of 11 suggestive of clinically relevant anxiety. Plasma CT-proET-1 levels were significantly lower in the group of anxious patients as compared to non-anxious patients (p = 0.013). In regression models adjusted for sex, age, systolic blood pressure, and diameters of left atrium and ventricle, plasma CT-proET-1 was again linked to anxiety (Exp(β) = 0.247, 95%-confidence interval [95%-CI] = 0.067–0.914, p = 0.036). Given the high prevalence of depressive disorders in anxious patients, we additionally included the HADS depression score as an independent variable in the models and found that CT-proET-1 remained a significant predictor of anxiety, independent of comorbid depression (Exp(β) = 0.114, 95%-CI = 0.023–0.566, p = 0.008). Our data from a population-based study in outpatients with cardiovascular risk factors revealed that circulating CT-proET-1 levels are negatively associated with anxiety. Further investigations are required to clarify the putative anxiolytic effect of ET-1 or its precursor molecules in humans and to decipher its mechanistic pathways.